NephU Podcast

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

This podcast, featuring Melanie Betz, MS, RD, CSR, CSG, LDN, will examine the barriers and current recommendation practices of plant-based diets to patients with kidney disease from the nephrology professionals’ perspective.

For more content like this please visit https://nephu.org

*Melanie Betz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Sushma Shiravanthe is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

December 2022 US.CORP.X.22.00879

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

NephU hosts veteran nephrology editor Mark Neumann to discuss some of the updates finalized in the ESRD PPS rule for 2023, and their implications for providers in the kidney care community.

For more content like this please visit https://nephu.org

*Mark Neumann is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

December 2022 US.CORP.X.22.00873

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

NephU hosts veteran nephrology editor Mark Neumann to discuss how kidney care providers prepared ahead of the storm and how the storm impacted the kidney community.

For more content like this please visit https://nephu.org

*Mark Neumann is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

October 2022 US.CORP.X.22.00771

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In this episode of Hot Topics in Nephrology, Mark Neumann describes a measure on the November ballot in California that will increase oversight in dialysis facilities operating in the state.

For more content like this please visit https://nephu.org

*Mark Neumann is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

September 2022 US.CORP.X.22.00672

Comments On The Management Of Procured Organs From August 3, 2022 Capital Hill Hearing

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In this episode, NephU hosts veteran nephrology editor Mark Neumann to discuss some of the updates from a recent hearing on Capital Hill regarding the bipartisan investigation into the United Network of Organ Sharing (UNOS). The committee shared their concerns with UNOS’s oversight of the U.S. Organ Procurement and Transplantation Network (OPTN), specifically concerning its policy compliance and patient safety activities related to organ procurement organizations (OPOs).

For more content like this please visit https://nephu.org

*Mark Neumann is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

August 2022 US.CORP.X.22.00613

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In alignment with National Donate Life Month, the NephU Community wanted to explore the transplant journey, where we walk through the pre- and post-transplant process, including candidate selection, access issues and barriers, concerns around medication adherence, regimen complexity, and medication errors, and potential solutions to tackle some of these problems. This episode is part 2 of this series, where we will specifically dive into the post-transplant journey.

For more content like this please visit https://nephu.org

Featuring the following speakers:

Josh Gariboldi, PharmD, BCPS (moderator)

Nephrology Clinical & Scientific Liaison, Otsuka

Dave Taber, PharmD, MS (panelist/speaker)

Clinical Pharmacy Specialist, Transplantation, VA in Charleston, SC

Professor, Division of Transplant Surgery, College of Medicine, MUSC

Dr Dave Taber is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Dr Josh Gariboldi is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

April 2022 US.CORP.X.22.00247

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In alignment with National Donate Life Month, the NephU Community wanted to explore the transplant journey, where we will walk through the pre- and post-transplant process, including candidate selection, access issues and barriers, concerns around medication adherence, regimen complexity, and medication errors, and potential solutions to tackle some of these problems. This episode will focus on the pre-transplant journey – we have another one planned to dive into the issues post-transplant.

For more content like this please visit https://nephu.org

Featuring the following speakers:

Josh Gariboldi, PharmD, BCPS (moderator)

Nephrology Clinical & Scientific Liaison, Otsuka

Dave Taber, PharmD, MS (panelist/speaker)

Clinical Pharmacy Specialist, Transplantation, VA in Charleston, SC

Professor, Division of Transplant Surgery, College of Medicine, MUSC

Dr Dave Taber is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Dr Josh Gariboldi is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

April 2022 US.CORP.X.22.00246

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In this episode, Sean George P.A.-C, Senior Medical Science Liaison and Dr Edgar Lerma will be discussing the topic of diabetic kidney disease (DKD). This episode will focus in on providing an overview of the pathophysiology, epidemiology, clinical manifestations, and general management of the disease.

For more content like this please visit https://nephu.org

*Dr Edgar Lerma is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Sean George is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

August 2021 US.CORP.X.21.00530 / August 2021 US.CORP.X.21.00532

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In this episode, Medical Science Liaison Sean George, PA-C, MHS and Dr Edgar Lerma MD will be discussing hypertensive nephrosclerosis. The episode will provide a brief overview of the pathophysiology, clinical features, diagnosis, non-pharmacologic and pharmacological treatments of the disease.

For more content like this please visit https://nephu.org

*Dr Edgar Lerma is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Sean George is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

August 2021 US.CORP.X.21.00530 / January 2021 MRC1.CORP.V.00199

Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.

In this podcast, Dr Laura Frank, Nephrology Medical Science Liaison will have a dialogue about Ms Betz’s Letter to the Editor in the Journal of Renal Nutrition: MNT in a Virtual World: A Renal Dietitian’s Perspective. This podcast will discuss Ms Betz’s perspective on the Pros and Cons of TeleNutrition, how important it is for the Centers of Medicare and Medicaid Services to reimburse for TeleNutrition, how TeleNutrition has incentivized her as a provider to utilize this type of care model, and how can TeleNutrition help address the Executive Order of 2019: ‘‘Advancing American Kidney Health’’ initiative and improve kidney care and outcomes.

For more content like this please visit https://nephu.org

*Melanie Betz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Laura Frank is an employee of OPDC.

Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.

May 2021 US.CORP.X.21.00179 / May 2021 US.CORP.V.21.00013